Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil

Bibliographic Details
Main Author: Filho, Carlos Izaias Sartorão
Publication Date: 2023
Other Authors: Zoqui, Mariana Costa, Duarte, Douglas Otomo, Ribeiro, Edy Alyson, Bisetto, Vinicius César Queiroz, Cachoni, Lara Escobar Gavião, Sartorão, Ana Luísa Varrone, Terribile, Diogo Coutinho, Mello, Beatriz Balsimelli de, Neto, Carlos Izaias Sartorão, Mello, Roberto de
Format: Article
Language: eng
Source: São Paulo medical journal (Online)
Download full: https://periodicosapm.emnuvens.com.br/spmj/article/view/469
Summary: BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.
id APM-1_12a9fb37d1b170081e629b7c7a9b4526
oai_identifier_str oai:ojs.diagnosticoetratamento.emnuvens.com.br:article/469
network_acronym_str APM-1
network_name_str São Paulo medical journal (Online)
repository_id_str
spelling Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of BrazilCOVID-19Vaccination hesitancyVaccinationVaccination refusalAnti-vaccination movementBACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.São Paulo Medical JournalSão Paulo Medical Journal2023-05-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicosapm.emnuvens.com.br/spmj/article/view/469São Paulo Medical Journal; Vol. 141 No. 3 (2023); 1-7São Paulo Medical Journal; v. 141 n. 3 (2023); 1-71806-9460reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APMenghttps://periodicosapm.emnuvens.com.br/spmj/article/view/469/423https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFilho, Carlos Izaias SartorãoZoqui, Mariana CostaDuarte, Douglas OtomoRibeiro, Edy AlysonBisetto, Vinicius César QueirozCachoni, Lara Escobar GaviãoSartorão, Ana Luísa VarroneTerribile, Diogo CoutinhoMello, Beatriz Balsimelli deNeto, Carlos Izaias SartorãoMello, Roberto de2023-07-07T12:22:24Zoai:ojs.diagnosticoetratamento.emnuvens.com.br:article/469Revistahttp://www.scielo.br/spmjPUBhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2023-07-07T12:22:24São Paulo medical journal (Online) - Associação Paulista de Medicinafalse
dc.title.none.fl_str_mv Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
spellingShingle Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
Filho, Carlos Izaias Sartorão
COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
title_short Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_full Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_fullStr Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_full_unstemmed Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
title_sort Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
author Filho, Carlos Izaias Sartorão
author_facet Filho, Carlos Izaias Sartorão
Zoqui, Mariana Costa
Duarte, Douglas Otomo
Ribeiro, Edy Alyson
Bisetto, Vinicius César Queiroz
Cachoni, Lara Escobar Gavião
Sartorão, Ana Luísa Varrone
Terribile, Diogo Coutinho
Mello, Beatriz Balsimelli de
Neto, Carlos Izaias Sartorão
Mello, Roberto de
author_role author
author2 Zoqui, Mariana Costa
Duarte, Douglas Otomo
Ribeiro, Edy Alyson
Bisetto, Vinicius César Queiroz
Cachoni, Lara Escobar Gavião
Sartorão, Ana Luísa Varrone
Terribile, Diogo Coutinho
Mello, Beatriz Balsimelli de
Neto, Carlos Izaias Sartorão
Mello, Roberto de
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Filho, Carlos Izaias Sartorão
Zoqui, Mariana Costa
Duarte, Douglas Otomo
Ribeiro, Edy Alyson
Bisetto, Vinicius César Queiroz
Cachoni, Lara Escobar Gavião
Sartorão, Ana Luísa Varrone
Terribile, Diogo Coutinho
Mello, Beatriz Balsimelli de
Neto, Carlos Izaias Sartorão
Mello, Roberto de
dc.subject.por.fl_str_mv COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
topic COVID-19
Vaccination hesitancy
Vaccination
Vaccination refusal
Anti-vaccination movement
description BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.
publishDate 2023
dc.date.none.fl_str_mv 2023-05-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/469
url https://periodicosapm.emnuvens.com.br/spmj/article/view/469
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://periodicosapm.emnuvens.com.br/spmj/article/view/469/423
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
publisher.none.fl_str_mv São Paulo Medical Journal
São Paulo Medical Journal
dc.source.none.fl_str_mv São Paulo Medical Journal; Vol. 141 No. 3 (2023); 1-7
São Paulo Medical Journal; v. 141 n. 3 (2023); 1-7
1806-9460
reponame:São Paulo medical journal (Online)
instname:Associação Paulista de Medicina
instacron:APM
instname_str Associação Paulista de Medicina
instacron_str APM
institution APM
reponame_str São Paulo medical journal (Online)
collection São Paulo medical journal (Online)
repository.name.fl_str_mv São Paulo medical journal (Online) - Associação Paulista de Medicina
repository.mail.fl_str_mv revistas@apm.org.br
_version_ 1825135056706863104